Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 149

Similar articles for PubMed (Select 19361855)

1.

Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.

When To Start Consortium, Sterne JA, May M, Costagliola D, de Wolf F, Phillips AN, Harris R, Funk MJ, Geskus RB, Gill J, Dabis F, Miró JM, Justice AC, Ledergerber B, Fätkenheuer G, Hogg RS, Monforte AD, Saag M, Smith C, Staszewski S, Egger M, Cole SR.

Lancet. 2009 Apr 18;373(9672):1352-63. doi: 10.1016/S0140-6736(09)60612-7. Epub 2009 Apr 8. Review.

2.

Encephalopathy in HIV patients on antiretroviral therapy.

Kishida S.

Rinsho Shinkeigaku. 2015;55(6):435-6. doi: 10.5692/clinicalneurol.cn-000663. No abstract available.

PMID:
26103821
3.

CD4+ cell count responses to antiretroviral therapy are not impaired in HIV-infected individuals with tuberculosis co-infection.

Gupta RK, Brown AE, Zenner D, Rice B, Yin Z, Thomas HL, Pozniak A, Abubakar I, Delpech V, Lipman M.

AIDS. 2015 Jul 17;29(11):1363-8. doi: 10.1097/QAD.0000000000000685.

PMID:
26091298
4.

Effects of highly active antiretroviral therapy on the survival of HIV-infected adult patients in urban slums of Kenya.

Muhula SO, Peter M, Sibhatu B, Meshack N, Lennie K.

Pan Afr Med J. 2015 Jan 22;20:63. doi: 10.11604/pamj.2015.20.63.4865. eCollection 2015.

5.

Age-Old Questions: When to Start Antiretroviral Therapy and in Whom?

Walensky RP, Hirsch MS.

Clin Infect Dis. 2015 Jun 16. pii: civ467. [Epub ahead of print] No abstract available.

PMID:
26082510
6.

Age at entry into care, timing of antiretroviral therapy initiation, and 10-year mortality among HIV-seropositive adults in the United States.

Edwards JK, Cole SR, Westreich D, Mugavero MJ, Eron JJ, Moore RD, Mathews WC, Hunt P, Williams C; CNICS investigators.

Clin Infect Dis. 2015 Jun 16. pii: civ463. [Epub ahead of print]

PMID:
26082505
7.

Accounting for dropout reason in longitudinal studies with nonignorable dropout.

Moore CM, MaWhinney S, Forster JE, Carlson NE, Allshouse A, Wang X, Routy JP, Conway B, Connick E.

Stat Methods Med Res. 2015 Jun 15. pii: 0962280215590432. [Epub ahead of print]

PMID:
26078357
8.

Factors Associated with Timing of Initiation of Antiretroviral Therapy among HIV-1 Infected Adults in the Niger Delta Region of Nigeria.

Ogoina D, Finomo F, Harry T, Inatimi O, Ebuenyi I, Tariladei WW, Afolayan AA.

PLoS One. 2015 May 1;10(5):e0125665. doi: 10.1371/journal.pone.0125665. eCollection 2015.

9.

A Bundle of Services Increased Ascertainment of Tuberculosis among HIV-Infected Individuals Enrolled in a HIV Cohort in Rural Sub-Saharan Africa.

Haraka F, Glass TR, Sikalengo G, Gamell A, Ntamatungiro A, Hatz C, Tanner M, Furrer H, Battegay M, Letang E.

PLoS One. 2015 Apr 21;10(4):e0123275. doi: 10.1371/journal.pone.0123275. eCollection 2015.

10.

A Comparison of Seven Cox Regression-Based Models to Account for Heterogeneity Across Multiple HIV Treatment Cohorts in Latin America and the Caribbean.

Giganti MJ, Luz PM, Caro-Vega Y, Cesar C, Padgett D, Koenig S, Echevarria J, McGowan CC, Shepherd BE.

AIDS Res Hum Retroviruses. 2015 May;31(5):496-503. doi: 10.1089/AID.2014.0241. Epub 2015 Mar 6.

PMID:
25647087
11.

Improved survival with co-trimoxazole prophylaxis among people living with HIV/AIDS who initiated antiretroviral treatment in Henan Province, China.

Zhu Q, Wang L, Lin W, Bulterys M, Yang W, Sun D, Cui Z, Kaplan J, Kleinman N, Wei X, Chung J, Wang Z.

Curr HIV Res. 2014;12(5):359-65.

PMID:
25426939
12.

Short Communication: HIV RNA Levels Predict AIDS-Defining and Non-AIDS-Defining Cancers After Antiretroviral Therapy Initiation Among HIV-Infected Adults.

Crum-Cianflone NF, Wang X, Ganesan A, Okulicz J, Weintrob A, Lalani T, Agan B.

AIDS Res Hum Retroviruses. 2015 May;31(5):514-8. doi: 10.1089/AID.2014.0279. Epub 2014 Dec 17.

PMID:
25417712
13.

Heroin Use and HIV Disease Progression: Results from a Pilot Study of a Russian Cohort.

Edelman EJ, Cheng DM, Krupitsky EM, Bridden C, Quinn E, Walley AY, Lioznov DA, Blokhina E, Zvartau E, Samet JH.

AIDS Behav. 2015 Jun;19(6):1089-97. doi: 10.1007/s10461-014-0948-z.

PMID:
25413642
14.

Survival of AIDS patients in Sao Paulo-Brazil in the pre- and post-HAART eras: a cohort study.

Tancredi MV, Waldman EA.

BMC Infect Dis. 2014 Nov 15;14:599. doi: 10.1186/s12879-014-0599-8.

15.

Timing of antiretroviral therapy initiation in a nationally representative sample of HIV-infected adults receiving medical care in the United States.

Adedinsewo DA, Wei SC, Robertson M, Rose C, Johnson CH, Dombrowski J, Skarbinski J.

AIDS Patient Care STDS. 2014 Dec;28(12):613-21. doi: 10.1089/apc.2014.0194.

PMID:
25329710
16.

Delayed HIV diagnosis and initiation of antiretroviral therapy: inequalities by educational level, COHERE in EuroCoord.

Socio-economic Inequalities and HIV Writing Group for Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord, Lodi S, Dray-Spira R, Touloumi G, Braun D, Teira R, D'Arminio Monforte A, Gallois A, Zangerle R, Spire B, Dabis F, Stähelin C, Termote M, Kirk O, Chêne G, Egger M, del Amo J.

AIDS. 2014 Sep 24;28(15):2297-306. doi: 10.1097/QAD.0000000000000410.

PMID:
25313585
17.

Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies.

Boulle A, Schomaker M, May MT, Hogg RS, Shepherd BE, Monge S, Keiser O, Lampe FC, Giddy J, Ndirangu J, Garone D, Fox M, Ingle SM, Reiss P, Dabis F, Costagliola D, Castagna A, Ehren K, Campbell C, Gill MJ, Saag M, Justice AC, Guest J, Crane HM, Egger M, Sterne JA.

PLoS Med. 2014 Sep 9;11(9):e1001718. doi: 10.1371/journal.pmed.1001718. eCollection 2014 Sep.

18.

Beyond core indicators of retention in HIV care: missed clinic visits are independently associated with all-cause mortality.

Mugavero MJ, Westfall AO, Cole SR, Geng EH, Crane HM, Kitahata MM, Mathews WC, Napravnik S, Eron JJ, Moore RD, Keruly JC, Mayer KH, Giordano TP, Raper JL; Centers for AIDS Research Network of Integrated Clinical Systems (CNICS).

Clin Infect Dis. 2014 Nov 15;59(10):1471-9. doi: 10.1093/cid/ciu603. Epub 2014 Aug 4.

PMID:
25091306
19.

The impact of HAART initiation timing on HIV-TB co-infected patients, a retrospective cohort study.

Yang CH, Chen KJ, Tsai JJ, Lin YH, Cheng SH, Wang KF, Chiou HY.

BMC Infect Dis. 2014 Jun 4;14:304. doi: 10.1186/1471-2334-14-304.

20.

Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective, international, randomised, placebo-controlled trial.

Mfinanga SG, Kirenga BJ, Chanda DM, Mutayoba B, Mthiyane T, Yimer G, Ezechi O, Connolly C, Kapotwe V, Muwonge C, Massaga J, Sinkala E, Kohi W, Lyantumba L, Nyakoojo G, Luwaga H, Doulla B, Mzyece J, Kapata N, Vahedi M, Mwaba P, Egwaga S, Adatu F, Pym A, Joloba M, Rustomjee R, Zumla A, Onyebujoh P.

Lancet Infect Dis. 2014 Jul;14(7):563-71. doi: 10.1016/S1473-3099(14)70733-9. Epub 2014 May 5. Erratum in: Lancet Infect Dis. 2014 Jul;14(7):548.

PMID:
24810491
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk